Nick Daneman
Impact in
-
- Antibiotic Use and Resistance
-
- Antibiotic Resistance in Bacteria
Papers in
-
- Sepsis Diagnosis and Treatment 4
-
- Antibiotic Use and Resistance 4
- Co-authors
- Yaseen M. Arabi (1 shared paper)Sameera Aljohani (1 shared paper)Majid M. Alshamrani (1 shared paper)Anastasia Oikonomou (1 shared paper)Jerome A. Leis (1 shared paper)Ruxandra Pinto (2 shared papers)Emily G. McDonald (1 shared paper)Jennifer Grant (1 shared paper)
- Journals
- Open Forum Infectious Diseases (2 papers)JAMA Network Open (1 paper)JAMA (1 paper)PLoS ONE (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)
- Partner nations
- CanadaAustraliaSwitzerland
In The Last Decade
Nick Daneman
5 papers receiving 11 citations
Peers
Comparison fields: 5 of 11
- Applied Microbiology and Biotechnology 8
- Molecular Medicine 3
- Clinical Biochemistry 4
- Critical Care and Intensive Care Medicine 2
- Pharmacology 3
Countries citing papers authored by Nick Daneman
This map shows the geographic impact of Nick Daneman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Daneman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Daneman more than expected).
Fields of papers citing papers by Nick Daneman
This network shows the impact of papers produced by Nick Daneman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Daneman. The network helps show where Nick Daneman may publish in the future.
Co-authors
The 25 scholars most cited alongside Nick Daneman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2018 | 4 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 1 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 0 |
About Nick Daneman
Nick Daneman is a scholar working on Epidemiology, Applied Microbiology and Biotechnology, Clinical Biochemistry, Infectious Diseases and Critical Care and Intensive Care Medicine, having authored 7 papers that have together received 11 indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (4 papers), Antibiotic Use and Resistance (4 papers), Bacterial Identification and Susceptibility Testing (2 papers), Biomedical Ethics and Regulation (1 paper), COVID-19 diagnosis using AI (1 paper), Statistical Methods in Clinical Trials (1 paper), Meta-analysis and systematic reviews (1 paper) and Nosocomial Infections in ICU (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (8 citations), Molecular Medicine (3 citations), Clinical Biochemistry (4 citations), Critical Care and Intensive Care Medicine (2 citations) and Pharmacology (3 citations). Nick Daneman has collaborated with scholars based in Canada, Australia and Switzerland. Frequent co-authors include Yaseen M. Arabi, Sameera Aljohani, Majid M. Alshamrani, Anastasia Oikonomou, Jerome A. Leis, Ruxandra Pinto, Emily G. McDonald, Jennifer Grant, Angela Huttner and Rob Fowler. Their work appears in journals such as Open Forum Infectious Diseases, JAMA Network Open, JAMA, PLoS ONE and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.